IGF2 and metabolic dysfunction-associated steatotic liver disease: Even though insulin-like growth factor 2 (IGF2) has been reported to be overexpressed innonalcoholic fatty liver disease (NAFLD), its role in the progression of NAFLD and thepotential mechanism remain largely unclear.